International bonds: Takeda Pharmaceutical, 5.65% 5jul2044, USD (US874060BL90)
Senior Unsecured
Senior Unsecured
explore the most comprehensive database
800 000
bonds globally
Over 400
pricing sources
80 000
stocks
9 000
ETF
track your portfolio in the most efficient way
full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.
Register
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company in Japan. The companys drugs are marketed in approximately 90 countries worldwide. The company has an international marketing network, including Japan and 13 overseas bases in ...
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company in Japan. The companys drugs are marketed in approximately 90 countries worldwide. The company has an international marketing network, including Japan and 13 overseas bases in the U.S., Europe, and Asia. From these bases, the company markets its original products.The company operates its business in two categories, Pharmaceutical business and Other businesses. The Pharmaceutical business represents the ethical drug business and healthcare business. Other businesses include business activities involving the production and marketing of a range of products, including clinical diagnostics, photographic chemicals, and inorganic chemicals. In November 2009, Amylin Pharmaceuticals Inc. and Takeda Pharmaceutical Co. Ltd. announced that they have entered into a worldwide exclusive license, development and commercialization agreement to co-develop and commercialize pharmaceutical products for the treatment of obesity and related indications.Takeda Pharmaceutical Company Limited was founded in 1781.
|
|
|
|
|
explore the most comprehensive database
800 000
bonds globally
Over 400
pricing sources
80 000
stocks
9 000
ETF
track your portfolio in the most efficient way
full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.
Register2024 | |
2023 | |
2022 | |
2021 | |
2020 | |
2019 | |
2018 | |
2017 | |